{"id":3566,"date":"2026-10-09T14:42:21","date_gmt":"2026-10-09T06:42:21","guid":{"rendered":"http:\/\/www.siarnews.com\/blog\/?p=3566"},"modified":"2026-10-09T14:42:21","modified_gmt":"2026-10-09T06:42:21","slug":"what-are-the-labeling-requirements-for-products-after-downstream-processing-42d0-dc02d7","status":"publish","type":"post","link":"http:\/\/www.siarnews.com\/blog\/2026\/10\/09\/what-are-the-labeling-requirements-for-products-after-downstream-processing-42d0-dc02d7\/","title":{"rendered":"What are the labeling requirements for products after downstream processing?"},"content":{"rendered":"

If you\u2019ve ever ordered a vial of purified protein for a lab experiment, a batch of freeze-dried biopharmaceutical ingredient, or even a reagent for industrial food processing, you probably didn\u2019t think about the long chain of steps that got that product to your doorstep. For me, as a downstream processing supplier, that chain is my entire focus. My team designs and builds the equipment that takes raw biological or chemical feedstocks\u2014think cell culture broths, fermentation outputs, or crude chemical extracts\u2014and turns them into pure, usable products. But no matter how clever our equipment is, no matter how tight our quality controls, if the label on that final product doesn\u2019t meet global regulations, none of it matters. That\u2019s the truth we live and breathe every day at my company: downstream processing isn\u2019t just about purification. It\u2019s about making sure the product that leaves our facility is not only pure, but also compliant, safe, and clearly communicated to whoever uses it. Let\u2019s break down what labeling requirements for products after downstream processing actually mean, why they\u2019re non-negotiable, and how we help our clients navigate the messy, often conflicting rules that govern this space. Downstream Processing<\/a><\/p>\n

<\/p>\n

First, it\u2019s important to define what \u201cproducts after downstream processing\u201d actually refers to, because the rules change dramatically depending on what that product is. Downstream processing (DSP) is the series of steps that follow upstream processing\u2014like cell growth or fermentation\u2014to isolate, purify, and finish the target molecule or material. For biopharmaceutical clients, that could be a monoclonal antibody (mAb) for cancer treatment, a vaccine antigen, or a protein for enzyme replacement therapy. For industrial clients, it might be a food additive, a cosmetic ingredient, or a specialty chemical used in manufacturing. Each of these products falls under a different regulatory umbrella, and that means their labeling requirements are entirely separate. For example, a mAb intended for injection into a patient isn\u2019t the same as a protein used to clear food waste in a production line, so their labels can\u2019t be either.<\/p>\n

Let\u2019s start with the most heavily regulated category: biopharmaceuticals. If a product is going to be used in human or animal medicine, regulatory bodies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan have extremely specific rules. Back in 2021, I worked with a small biotech startup out of Boston that was preparing to run clinical trials for a new COVID-19 oral enzyme therapy. They\u2019d finished purification on our \u00c4KTA-style chromatography system, and their batches were ready for formulation. But when they reached out to me, panicking, they realized their draft labels were missing a critical requirement: a unique identifier for each batch, linked to traceability through every step of DSP. The FDA\u2019s 2019 Drug Supply Chain Security Act (DSCSA) requires that all prescription drugs have a 2D barcode on every package, with a unique serial number, lot number, expiration date, and product name. If that barcode is missing, or if the lot number on the label doesn\u2019t match the batch record from our DSP equipment, the biotech can\u2019t ship the product to trial sites. We ended up modifying our in-line labeling tool for their final packaging step to auto-populate that barcode from our system, so there was zero human error in matching the label to the batch data. That moment drove home something I see too often: many DSP-focused clients are great at purification, but terrible at translating that technical work into regulatory-compliant labels. That\u2019s why we\u2019ve built a whole support service around this part of the process now.<\/p>\n

For biopharma products, the labeling requirements don\u2019t stop at barcodes. There are also content requirements that vary by region. In the U.S., prescription drug labels need to include the established name of the drug, the strength, the dosage form, the route of administration, the lot number, expiration date, manufacturer name and address, and storage conditions. In the EU, on top of all that, labels must also include \u201cbatch release data\u201d that confirms the product meets all quality specifications set by the EMA\u2014something we\u2019re required to flag to our clients before a batch is released, because if the release data isn\u2019t on the label, the batch is considered invalid. Even something as simple as storage conditions can be a trap for new clients. Last year, a Canadian biotech working on a gene therapy vector labeled their final product \u201cstore at -20\u00b0C\u201d after DSP, but their clinical trial protocol required \u201cstore at -80\u00b0C.\u201d The EMA rejected their labeling because it didn\u2019t match the approved drug master file (DMF), and they had to re-package every batch, costing them six weeks of trial time. That\u2019s the kind of mistake that makes our job as a DSP supplier harder, but also more valuable: we don\u2019t just sell equipment. We review labels with our clients before they finalize batches, flagging discrepancies between their technical specs and regulatory rules.<\/p>\n

Now, if we move away from biopharmaceuticals to the next largest category of DSP products: food and food ingredients. The rules here are set by bodies like the U.S. Food Safety and Inspection Service (FSIS) and the EU\u2019s European Food Safety Authority (EFSA), and they\u2019re just as strict, but often more focused on transparency for consumers. For example, if a dairy processor uses our membrane filtration system to purify whey protein for use in protein bars, the label on that purified whey can\u2019t just say \u201cwhey protein\u201d\u2014it has to list its origin (cow milk), any processing aids used during DSP (like enzymes or filter aids), and allergen information, even if the allergen is removed during purification. Wait, that\u2019s a key point: even if a DSP step removes lactose or casein from whey, if the processing line was shared with milk products, the label still has to note a potential cross-contamination risk, because EFSA requires that. We had a client in Germany last year that made plant-based meat products, and their purified pea protein had a tiny trace of soy from a shared DSP processing line. They wanted to omit soy from the label, thinking the DSP had removed all traces, but EFSA\u2019s 2020 allergen labeling update requires that any potential cross-contact from shared equipment during DSP must be disclosed, even if it\u2019s below the limit of detection. That\u2019s a rule that\u2019s easy to miss when you\u2019re deep in the technical side of purification. We now include a pre-labeling audit as a standard part of our food-grade DSP system delivery, because skipping that step leads to rejected batches at customs or retail shelves\u2014something no food processor can afford, especially with tight margins.<\/p>\n

The third big category of DSP products is industrial materials: specialty chemicals, cosmetic ingredients, and agricultural inputs like plant growth regulators. These are often less heavily regulated than biopharma or food, but that doesn\u2019t mean labeling requirements are loose. For example, in the U.S., the Occupational Safety and Health Administration (OSHA)\u2019s Hazard Communication Standard (HazCom) requires that all chemical products have a Global Harmonized System (GHS) label, with hazard symbols, signal words, hazard statements, and precautionary statements. If a client is using our solvent extraction DSP system to purify a specialty chemical for use in cleaning products, the label on the final drum can\u2019t just say \u201cspecialty solvent\u201d\u2014it has to note that it\u2019s flammable, irritates skin, and requires personal protective equipment when handling. I remember a small chemical manufacturing startup in Ohio that used our DSP system to purify a new plasticizer. They forgot that the GHS label requires the product\u2019s Chemical Abstracts Service (CAS) number, which is a unique identifier for the chemical. Without that number, OSHA fines can run into thousands of dollars per batch, even if there\u2019s no safety issue with the product. We added a tool to our DSP control software that auto-generates the correct GHS label for industrial chemical products, pulling the CAS number and hazard data from a global database, so our clients don\u2019t have to look it up themselves. That\u2019s been a game-changer for clients who don\u2019t have a dedicated regulatory team.<\/p>\n

But here\u2019s the thing that makes labeling requirements for DSP products so complicated: rules aren\u2019t global. A product that\u2019s compliant for sale in the U.S. might not be compliant in Australia, Brazil, or South Korea. For example, the EU\u2019s REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation requires that every chemical product sold in the EU has a unique registration number, which has to be on the label. A client that sells a personal care ingredient purified on our DSP system to the EU has to have that registration number, otherwise they can\u2019t ship it. I worked with a U.S. cosmetic ingredient maker last year that was shipping to the EU, and their labels didn\u2019t have the REACH number, because they\u2019d thought it was just an internal document for the supplier. We had to help them navigate the REACH registration process, which took three months, and during that time, they lost a major contract with a European beauty brand. That\u2019s why we now have a network of regulatory consultants on call, specializing in different regions, to help our clients with cross-border labeling compliance. We don\u2019t just sell equipment\u2014we\u2019re a resource for navigating the global regulatory maze.<\/p>\n

Another often-overlooked part of DSP product labeling is batch traceability. When you\u2019re dealing with products that could be dangerous if something goes wrong (think a toxic chemical or a contaminated vaccine), regulators need to be able to trace every batch back to its original feedstock, every step of DSP, every operator, and every piece of equipment used. That means the label on the final product has to have enough lot and batch information to make that traceability possible. For biopharma products, the FDA\u2019s DSCSA and EMA\u2019s Falsified Medicines Directive (FMD) require that lot numbers are linked to every step of DSP, so if a batch is recalled, regulators can quickly find every unit that was shipped. For food products, FSIS requires that the lot number on the label can be traced back to the raw milk or grain, so if there\u2019s a salmonella outbreak, processors can isolate the exact source. We\u2019ve designed our DSP control systems to log every detail of a batch\u2014when it was processed, which column or filter was used, which operator ran it, what the purity level was\u2014and then generate a QR code or barcode on the final label that links directly to that batch data. That means if a client needs to do a recall, they don\u2019t have to spend days digging through paper records; they can scan the label and have every detail in seconds.<\/p>\n

I think a lot of people outside our industry see downstream processing as just the \u201cdirty work\u201d of turning raw materials into something usable. But from where I stand, it\u2019s the most important step between a raw feedstock and a safe, compliant product. The labeling requirements aren\u2019t just red tape\u2014they\u2019re there to protect patients, consumers, workers, and the environment. And as a DSP supplier, our job is to make those requirements as easy as possible for our clients to meet. We\u2019ve seen too many small biotechs, food processors, and chemical startups fail because they got so focused on perfecting their purification process that they forgot about labeling. That\u2019s why we invest so much time in understanding the latest regulations across every region and product category, and building tools and support to help our clients comply.<\/p>\n

If you\u2019re a lab manager at a biotech, a quality control lead at a food processor, or a product development manager at a chemical company, and you\u2019re working on a downstream processing project\u2014whether you\u2019re purifying a new drug, a food ingredient, or an industrial material\u2014don\u2019t let labeling requirements derail your work. We\u2019ve helped hundreds of clients across industries navigate these rules, from the initial design of their DSP system all the way through to final labeling and batch release. We can help you audit your draft labels for compliance, adjust your DSP equipment to auto-generate regulatory-approved labels, or connect you with our network of regional regulatory experts to make cross-border sales easy. For too long, DSP suppliers have focused only on purification efficiency, but we think it\u2019s time to put compliance at the center of what we do. The product that leaves your facility shouldn\u2019t just be pure\u2014it should be ready to sell, safe to use, and fully compliant with every rule that applies to it.<\/p>\n

<\/p>\n

If you have questions about labeling requirements for your specific DSP product, or you\u2019d like to learn how we can support your next project, reach out to our team to schedule a consultation. We\u2019re here to help you get it right, on time, and without the regulatory headaches.<\/p>\n

Tangential Flow Filtration System<\/a> References<\/p>\n

    \n
  1. U.S. Food and Drug Administration. (2019). Drug Supply Chain Security Act (DSCSA) Final Rule.<\/li>\n
  2. European Medicines Agency. (2020). Falsified Medicines Directive (FMD) Labeling Requirements for Human Medicinal Products.<\/li>\n
  3. U.S. Food Safety and Inspection Service. (2022). Food Allergen Labeling and Consumer Protection Act (FALCPA) Updated Guidelines.<\/li>\n
  4. European Food Safety Authority. (2020). Cross-Contamination Allergen Labeling Requirements for Processed Food Ingredients.<\/li>\n
  5. Occupational Safety and Health Administration. (2023). Hazard Communication Standard (HazCom) 2012 Update on GHS Labeling.<\/li>\n
  6. European Chemicals Agency. (2021). REACH Regulation Labeling and Registration Requirements for Industrial Chemicals.<\/li>\n<\/ol>\n
    \n

    Hangzhou Guidling Technology Co., Ltd.<\/a><\/p>\n

    Address: No.795, 18th Street, Qiantang New District, Hangzhou City, Zhejiang Province, China
    E-mail: export1@guidling.net
    WebSite:     https:\/\/www.guidlingfiltration.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    If you\u2019ve ever ordered a vial of purified protein for a lab experiment, a batch of … What are the labeling requirements for products after downstream processing?<\/span>Read more<\/a><\/p>\n","protected":false},"author":580,"featured_media":3566,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3529],"class_list":["post-3566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-downstream-processing-40c2-dc4af0"],"_links":{"self":[{"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/posts\/3566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/users\/580"}],"replies":[{"embeddable":true,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/comments?post=3566"}],"version-history":[{"count":0,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/posts\/3566\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/posts\/3566"}],"wp:attachment":[{"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/media?parent=3566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/categories?post=3566"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.siarnews.com\/blog\/wp-json\/wp\/v2\/tags?post=3566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}